Skip to content
Boca Raton City Online – Lifestyle
Author:
SOLIGENIX, INC.
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet’s Disease
March 8, 2026
Soligenix to Present at BIO Investment & Growth Summit
March 7, 2026
Soligenix Details Recent Progress and Upcoming Milestones
March 6, 2026
←
Previous Page
1
2